Wexford Capital’s Aravive, Inc. Common Stock ARAV Stock Holding History

Wexford Capital’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,661	Closed	-$38K	–	377
2020 Q4	$38K	Buy	+6,661	New	+$36.6K	0.01%	274

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wexford Capital's ARAV Position: Q1 2021 in Review

Wexford Capital sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2021, closing a stake of 6,661 shares — an estimated $38K sold.

Wexford Capital first reported a position in ARAV in Q4 2020 and held it in 1 quarter. The position peaked at $38K in Q4 2020. 59 funds tracked by Wall St. Rank hold ARAV as of Q1 2021.

Wexford Capital reported no remaining Aravive, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Wexford Capital sold 6,661 Aravive, Inc. Common Stock shares in Q1 2021, an estimated $38K.
Wexford Capital first reported a position in Aravive, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Wexford Capital's Aravive, Inc. Common Stock position peaked at $38K in Q4 2020.
59 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.